Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Young

Showing results (921-930 of 2,347) with videos related to

Pageof 235
Sort By:
Drug Intelligence & Clinical Pharmacy|March 1, 1987
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapyR P Rapp, B Young, K Bertch, et al.
The American Journal of Physiology|September 1, 1976
Effectiveness of the aldosterone-sodium and -potassium feedback control systemD B Young, R E McCaa, U J Pan, et al.
Annals of Neurology|March 1, 1979
Oral phenytoin loading in adults: rapid achievement of therapeutic plasma levelsK E Record, R P Rapp, A B Young, et al.
Neuroscience Letters|July 6, 1992
Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the ratS J Tallaksen-Greene, A B Young, J B Penney, et al.
Journal of Neurosurgery|October 1, 1978
Studies of experimental cervical spinal cord transection. Part I: Hemodynamic changes after acute cervical spinal cord transectionP A Tibbs, B Young, R G McAllister, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1986
The role of myo-inositol in multiple sclerosisG B Young, W J Hader, M Hiscock, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complexJ J Hsieh, S Zhou, L Chen, et al.
Journal of Neurochemistry|February 1, 1990
Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sitesE O Nielsen, J Drejer, J H Cha, et al.
Journal of Neurosurgery|September 1, 1988
Mechanisms and implications of hypoalbuminemia in head-injured patientsC J McClain, B Hennig, L G Ott, et al.
Journal of the American College of Cardiology|April 23, 2003
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failureW H Wilson Tang, Gary S Francis, Byron J Hoogwerf, et al.
Pageof 235

Showing results (921-930 of 2,347) with videos related to

Sort By:
Pageof 235
Drug Intelligence & Clinical Pharmacy|March 1, 1987
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapyR P Rapp, B Young, K Bertch, et al.
The American Journal of Physiology|September 1, 1976
Effectiveness of the aldosterone-sodium and -potassium feedback control systemD B Young, R E McCaa, U J Pan, et al.
Annals of Neurology|March 1, 1979
Oral phenytoin loading in adults: rapid achievement of therapeutic plasma levelsK E Record, R P Rapp, A B Young, et al.
Neuroscience Letters|July 6, 1992
Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the ratS J Tallaksen-Greene, A B Young, J B Penney, et al.
Journal of Neurosurgery|October 1, 1978
Studies of experimental cervical spinal cord transection. Part I: Hemodynamic changes after acute cervical spinal cord transectionP A Tibbs, B Young, R G McAllister, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1986
The role of myo-inositol in multiple sclerosisG B Young, W J Hader, M Hiscock, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complexJ J Hsieh, S Zhou, L Chen, et al.
Journal of Neurochemistry|February 1, 1990
Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sitesE O Nielsen, J Drejer, J H Cha, et al.
Journal of Neurosurgery|September 1, 1988
Mechanisms and implications of hypoalbuminemia in head-injured patientsC J McClain, B Hennig, L G Ott, et al.
Journal of the American College of Cardiology|April 23, 2003
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failureW H Wilson Tang, Gary S Francis, Byron J Hoogwerf, et al.
Pageof 235